Cited by 347Drug Solubulity and Delivery SystemsNanoparticle-Based Drug DeliveryAdvancements in Transdermal Drug Delivery

The DOI matches its Crossref record; 155 of the 159 references it cites were found in a registry or an index.

Drug nanocrystals: in vivo performances.

Gao, Lei, Liu, Guiyang, Ma, Jianli, Wang, Xiaoqing, Zhou, Liang, Li, Xiang·2012·Journal of Controlled Release

DOI 10.1016/j.jconrel.2012.03.013

Open this paper in CoChat — free account

Abstract

Over the past few decades, there has been a considerable research interest in drug nanocrystal system as a pharmaceutical approach for poorly soluble drugs. At the beginning lots of works have been done to study various technologies associated with production of drug nanocrystals and their in vitro physical and chemical properties, such as morphology, formulation composition, stabilities, crystalline structure and enhanced solubility and dissolution velocity. Recently, in vivo behaviors of the nanocrystals have been generally studied in animals (including human), and the results proved that drug nanocrystals could be used as a versatile formulation to alter and improve the pharmacokinetic, pharmacodynamic and targeting properties of poorly soluble drugs. In this paper, in vivo performances of drug nanocrystals exhibited in animals in different administration route were reviewed, and the advantages of drug nanocrystals in the aspect of safety, pharmacodynamics, pharmacokinetics and targeting delivery were discussed in detail.

Integrity signals

Registry

Crossref · 10.1016/j.jconrel.2012.03.013

Cites

155 of 155 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Long-Circulating and Target-Specific Nanoparticles: Theory to Practice
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01494-7 · Cited by 3,521
Nanoparticles in cancer therapy and diagnosis
Brigger, I., Dubernet, C., & Couvreur, P. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00044-3 · Cited by 3,040
Nanomedicine: current status and future prospects
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2005) · The FASEB Journal · doi:10.1096/fj.04-2747rev · Cited by 2,029
Nanosuspensions in drug delivery
Rabinow, B. E. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1494 · Cited by 1,529
Targeted drug delivery via the folate receptor
Sudimack, J. J., & Lee, R. J. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(99)00062-9 · Cited by 1,477
Nanosuspensions as particulate drug formulations in therapy
Müller, R. H., Jacobs, C., & Kayser, O. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00118-6 · Cited by 1,370
Inhaling medicines: delivering drugs to the body through the lungs
Patton, J. S., & Byron, P. R. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2153 · Cited by 1,370
Nanoparticles as potential oral delivery systems of proteins and vaccines: A mechanistic approach
des Rieux, A., Fievez, V., Garinot, M., Schneider, Y.-J., & Préat, V. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.08.013 · Cited by 1,305
Nanosizing: a formulation approach for poorly-water-soluble compounds
Merisko-Liversidge, E. M., Liversidge, G. G., & Cooper, E. R. (2003) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(02)00251-8 · Cited by 1,270

Flagged first, then by citations

Show all 159 references

4 of the 159 references couldn’t be matched to a known paper.

Research works printed but not linked: 4

Lipinski, 2002, Poor aqueous solubility — an industry wide problem in drug discovery, Am. Pharm. Rev., 5, 82
des Rieux, 2006, Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach, J. Control. Release, 116, 1, 10.1016/j.jconrel.2006.08.013 · DOI · Paper page
Dressman, 2000, In vitro–in vivo correlations for lipophilic, poorly water-soluble drugs, Eur. J. Pharm. Sci., 11, S73, 10.1016/S0928-0987(00)00181-0 · DOI
Clement, 1992, Tissue distribution and plasma clearance of a novel microcrystalline-coated flurbiprofen formulation, Pharmacologist, 34, 204

Sorted by citations

Items 201–300 of 347

Functional drug nanocrystals for cancer-target delivery
Xiang, H., Xu, S., Li, J., Li, Y., Xue, X., Liu, Y., Li, J., & Miao, X. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.103807 · Cited by 16
In vitro–in vivo evaluation of nanosuspension release from subcutaneously implantable osmotic pumps
Hill, A., Geißler, S., Meyring, M., Hecht, S., Weigandt, M., & Mäder, K. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.04.060 · Cited by 15
The effect of different polymers on the solubility, permeability and distribution of poor soluble 1,2,4-thiadiazole derivative
Volkova, Т. V., Domanina, E. N., Kumeev, R. S., Proshin, A. N., & Terekhova, I. V. (2018) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2018.08.062 · Cited by 15
Metallic nanoparticulate delivery systems
Ahmad, M. Z., Ahmad, J., Warsi, M. H., Abdel‐Wahab, B. A., & Akhter, S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-08-102985-5.00013-9 · Cited by 15
Costunolide Loaded in pH-Responsive Mesoporous Silica Nanoparticles for Increased Stability and an Enhanced Anti-Fibrotic Effect
Niu, X., Wang, X., Niu, B., Meng, Y., He, H., Wang, Y., & Li, G. (2021) · Pharmaceuticals · doi:10.3390/ph14100951 · Cited by 16
Self-citation
Multiscale metal-based nanocomposites for bone and joint disease therapies
Wang, Y., Jan, H., Zheng, Z., Zhou, L., Teng, K., Chen, Y., Xu, J., Xie, D., Chen, D., Xu, J., et al. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.101773 · Cited by 17
Self-citation
High dose nanocrystalline solid dispersion powder of voriconazole for inhalation
Kaur, A., Dubey, G., Sharma, N., Pant, R., Bharatam, P. V., Tikoo, K., & Bansal, A. K. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.121827 · Cited by 14
The role of particle size of glyburide crystals in improving its oral absorption
Wang, Y., Yang, W., Fu, Q., Guo, Z., Sun, B., Liu, W., Liu, Y., Mu, S., Guo, M., Li, J., et al. (2017) · Drug Delivery and Translational Research · doi:10.1007/s13346-017-0378-3 · Cited by 14
Fabrication design, process technologies, and convolutions in the scale-up of nanotherapeutic delivery systems
Goel, H., Siddiqui, L., Mahtab, A., & Talegaonkar, S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820757-4.00017-x · Cited by 13
Development of Abiraterone Acetate Nanocrystal Tablets to Enhance Oral Bioavailability: Formulation Optimization, Characterization, In Vitro Dissolution and Pharmacokinetic Evaluation
Liu, Y., Li, Y., Xu, P., Shen, Y., Tang, B., & Wang, Q. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14061134 · Cited by 13
Novel amphiphilic hydroxyethyl starch-based nanoparticles loading camptothecin exhibit high anticancer activity in HepG2 cells and zebrafish
Wang, L., Liu, X., Zhang, C., Chen, X., Sheng, W., Li, P., Qin, D., & Wang, F. (2023) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2023.113215 · Cited by 14
Traditional Chinese medicine-based drug delivery systems for anti-tumor therapies
Ling, Y. A. N. G., Wang, Y., Ye, X., Liu, Q., Qu, D., & Chen, Y. (2024) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(24)60746-6 · Cited by 13
Denatured protein stabilized drug nanoparticles: tunable drug state and penetration across the intestinal barrier
He, W., Wang, Y., Lv, Y., Xiao, Q., Ye, L., Cai, B., Qin, C., Han, X., Cai, T., & Yin, L. (2016) · Journal of Materials Chemistry B · doi:10.1039/c6tb02577c · Cited by 13
Efavirenz Dissolution Enhancement IV—Antisolvent Nanocrystallization by Sonication, Physical Stability, and Dissolution
Sartori, G. J., Prado, L. D., & Rocha, H. V. A. (2017) · AAPS PharmSciTech · doi:10.1208/s12249-017-0781-6 · Cited by 13
Fabrication of polymer matrix-free nanocomposites based on Angelica gigas Nakai extract and their application to breast cancer therapy
Lee, S. Y., Lee, J.-J., Nam, S., Kang, W., Yoon, I., & Cho, H. (2017) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2017.08.040 · Cited by 13
Effects of Particle Size, Surface Nature and Crystal Type on Dissolution Rate
Sandri, G., Bonferoni, M. C., Rossi, S., Caramella, C. M., & Ferrari, F. (2018) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-3-319-94174-5_8 · Cited by 15
Preparation and Characterization of Anti-Cancer Crystal Drugs Based on Erythrocyte Membrane Nanoplatform
Ren, L., Qiu, L., Huang, B., Yin, J., Li, Y., Yang, X., & Chen, G. (2021) · Nanomaterials · doi:10.3390/nano11102513 · Cited by 13
Evaluating PAA/PVA thermal crosslinking process during the preparation of in-situ high-drug loading amorphous solid dispersions
Kapourani, A., Chachlioutaki, K., Andriotis, E. G., Fatouros, D. G., & Barmpalexis, P. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.104030 · Cited by 13
Effects of Nanosuspension Formulations on Transport, Pharmacokinetics, In Vivo Targeting and Efficacy for Poorly Water-soluble Drugs
Wang, Y., Miao, X., Sun, L., Song, J., Bi, C., Yang, X., & Zheng, Y. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990403 · Cited by 13
Nanosuspension formulations of poorly water‐soluble compounds for intravenous administration in exploratory toxicity studies: in vitro and in vivo evaluation
Fujimura, H., Komasaka, T., Tomari, T., Kitano, Y., & Takekawa, K. (2016) · Journal of Applied Toxicology · doi:10.1002/jat.3280 · Cited by 13
Roles of cryo/thermal strength for redispersibility of drug nanocrystals: a representative study with andrographolide
Xie, Y., Ma, Y., Xu, J., Dan, J., Yue, P., Wu, Z., Yang, M., & Zheng, Q. (2016) · Archives of Pharmacal Research · doi:10.1007/s12272-016-0732-x · Cited by 13
Evaluation of Different Techniques for Size Determination of Drug Nanocrystals: A Case Study of Celecoxib Nanocrystalline Solid Dispersion
Kaur, A., Parmar, P. K., & Bansal, A. K. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11100516 · Cited by 13
Preparation, characterization, and ex vivo evaluation of isoxanthohumol nanosuspension
Zhang, M., Liu, T., Tan, D., Liu, J., Gao, Y., Wang, H., Gao, F., & Zhixin, Y. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.124909 · Cited by 12
In vivo pharmacokinetic study and PBPK modeling: Comparison between 3D-printed nanocrystals and solid dispersions
López-Vidal, L., Tinti, M. G., Melian, M. E., Cantón, L., Lorenzutti, A. M., Schofs, L., Formica, M. L., Paredes, A. J., Bruni, S. F. S., Litterio, N. J., et al. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.125063 · Cited by 12
Nanocrystal Recovery by Use of Carrier Particles
Khan, S., de Matas, M., Plakkot, S., & Anwar, J. (2014) · Crystal Growth & Design · doi:10.1021/cg401432m · Cited by 12
Monocyte membrane-coated drug nanocrystals for enhanced targeted therapy of rheumatoid arthritis
Shi, R., Fu, J., Liu, Y., Zhang, A., Huang, S., Yang, X., Liang, Y., Quan, Y., He, S., Huang, S., et al. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.113919 · Cited by 11
Advances in Smart Nanopreparations for Oral Drug Delivery
Islan, G. A., Cacicedo, M. L., Bosio, V. E., & Castro, G. R. (2016) · IMPERIAL COLLEGE PRESS eBooks · doi:10.1142/9781783267231_0014 · Cited by 11
Overcoming the Low Oral Bioavailability of Deuterated Pyrazoloquinolinone Ligand DK-I-60-3 by Nanonization: A Knowledge-Based Approach
Mitrović, J. R., Divović, B., Knutson, D. E., Đoković, J. B., Kremenović, A., Dobričić, V., Randjelovic, D. V., Pantelić, I., Cook, J. M., Savić, M. M., et al. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13081188 · Cited by 11
Preparation and Pharmacokinetic Characterization of an Anti-Virulence Compound Nanosuspensions
Wang, N., Feng, Q., He, X., Shi, H., Anderson, D. W., Li, H., & Sun, H. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13101586 · Cited by 11
From Diagnosis to Treatment
Digesu, C. S., Hofferberth, S. C., Grinstaff, M. W., & Colson, Y. L. (2016) · Thoracic surgery clinics/Thorac. surg. clin. · doi:10.1016/j.thorsurg.2015.12.009 · Cited by 11
Polydopamine-coated nanocomposites of Angelica gigas Nakai extract and their therapeutic potential for triple-negative breast cancer cells
Nam, S., Lee, S. Y., Kim, J.-J., Kang, W., Yoon, I., & Cho, H. (2018) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2018.02.014 · Cited by 11
Development and Validation of an HPLC- UV Method for the Determination of Melphalan from Lyophilized Nanosuspension
Ashok, P., & Ananda, H. A. (2019) · Indian Journal of Pharmaceutical Education and Research · doi:10.5530/ijper.53.2.40 · Cited by 11
Clofazimine-Loaded Mucoadhesive Nanoparticles Prepared by Flash Nanoprecipitation for Strategic Intestinal Delivery
Yamada, K., Ristroph, K. D., Kaneko, Y., Lu, H. D., Sato, H., Prud’homme, R. K., & Onoue, S. (2021) · Pharmaceutical Research · doi:10.1007/s11095-021-03144-3 · Cited by 11
Oral Drug Delivery Systems Applied to Launched Products: Value for the Patients and Industrial Considerations
Yoshida, T., & Kojima, H. (2023) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.3c00482 · Cited by 10
Enhanced Solubility and Increased Bioavailability with Engineered Nanocrystals
Sood, R., Tomar, D., Kaushik, P., Sharma, P., Rani, N., Guarve, K., Dhankhar, S., & Garg, N. (2023) · Current Drug Therapy · doi:10.2174/0115748855269071231113070552 · Cited by 10
Nanosuspensions of a new compound, ER-β005, for enhanced oral bioavailability and improved analgesic efficacy
Ye, L., Miao, M., Li, S., & Hao, K. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.08.103 · Cited by 10
Pharmaceutical Drug Nanocrystals: Role in Dermal Delivery
Kumar, M., Shanthi, N., & Mahato, A. K. (2018) · Nanoscience & Nanotechnology-Asia · doi:10.2174/2210681208666180516093855 · Cited by 10
Preparation, characterization and ex vivo–in vivo assessment of candesartan cilexetil nanocrystals via solid dispersion technique using an alkaline esterase activator carrier
Amer, A. M., Allam, A. N., & Abdallah, O. Y. (2019) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2019.1600533 · Cited by 10
Besifloxacin Nanocrystal: Towards an Innovative Ophthalmic Preparation
de Jesus, J. I. S. D. S., Lourenço, F. R., Ishida, K., Barreto, T. L., Avino, V. C., Neto, E. D. S., & Bou‐Chacra, N. A. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14102221 · Cited by 10
Parenteral nanosuspension of a novel synthesized antitumor candidate: Investigation of tissue biodistributions and plasma pharmacokinetics
Tian, X., Han, L., Zhang, D., Shen, J., Jia, L., Zheng, D., Liu, G., Hao, L., Shen, Y., & Zhang, Q. (2013) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2013.08.029 · Cited by 10
Self-citation
Development of nanofunctionalized oxovanadium(IV) complex and its anticancer, antidiabetic, DNA cleavage and cell imaging studies
Sunitha, N., Raj, C. I. S., & Kumari, B. S. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.123339 · Cited by 9
Properties and bioaccessibility of arsenic sulphide nanosuspensions
Baláž, P., Bujňáková, Z. L., Kartachova, O., Fábian, M., & Stalder, B. (2013) · Materials Letters · doi:10.1016/j.matlet.2013.04.003 · Cited by 9
Dual drug nanocrystals loaded microparticles for fixed dose combination of simvastatin and ezetimibe
Nandi, S., Kaur, A., & Bansal, A. K. (2019) · Pharmaceutical Development and Technology · doi:10.1080/10837450.2019.1669181 · Cited by 9
Application of Fundamental Techniques for Physicochemical Characterizations to Understand Post-Formulation Performance of Pharmaceutical Nanocrystalline Materials
Witika, B. A., Aucamp, M. E., Mweetwa, L. L., & Makoni, P. A. (2021) · Crystals · doi:10.3390/cryst11030310 · Cited by 9
Intravenous nanocrystals: fabrication, solidification, in vivo fate, and applications for cancer therapy
Xia, Q., Shen, J., Ding, H., Liu, S., Li, F., Li, F., & Feng, N. (2023) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2023.2268512 · Cited by 8
Synthesis of Acid-Labile Poly(Doxazolidine) as a Polyprodrug with an Ultra-High Drug Content for Self-Delivery of High-Performance Chemotherapeutics
Li, J., Li, X., & Liu, P. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b00972 · Cited by 8
Self-citation
Drug nanocrystals as nanocarrier-based drug delivery systems
Arti, S., Bharti, M., Kumar, V., Saruchi, S., Rehani, V., & Dhiman, J. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824024-3.00018-x · Cited by 8
Recent Updates on Nanocarriers for Drug Delivery in Posterior Segment Diseases with Emphasis on Diabetic Retinopathy
Parashar, R., Vyas, A., Sah, A. K., Hemnani, N., Thangaraju, P., & Suresh, P. K. (2023) · Current Diabetes Reviews · doi:10.2174/0115733998240053231009060654 · Cited by 8
Preparation of multiparticulate systems for oral delivery of a micronized or nanosized poorly soluble drug
Cerea, M., Pattarino, F., Bonda, A. F., Palugan, L., Segale, L., & Vecchio, C. (2016) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2016.1143953 · Cited by 8
The emerging potential of crystalline drug‐polymer combination for medical applications
Shaheen‐Mualim, M., Kutner, N., & Farah, S. (2022) · Polymers for Advanced Technologies · doi:10.1002/pat.5687 · Cited by 8
Lyophilized Ethinylestradiol Nanosuspension: Fabrication, Characterization and Evaluation of in vitro Anticancer and Pharmacokinetic Study
Powar, T. A., & Hajare, A. A. (2020) · Indian Journal of Pharmaceutical Sciences · doi:10.36468/pharmaceutical-sciences.622 · Cited by 8
Absence of in vivo–in vitro correlation in per-oral drug delivery
Park, K. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.03.020 · Cited by 8
Quercetin nanocrystals for bioavailability enhancement: impact of different functional stabilizers on in vitro / in vivo drug performances
Zhu, Y., Hu, F., Shen, C., Shen, B., & Yuan, H. (2024) · Pharmaceutical Development and Technology · doi:10.1080/10837450.2024.2361654 · Cited by 7
Phytomedicine nanoformulations for Parkinson's disease
Saji, C. V., Mohanakumar, K. P., & Shenoi, R. A. (2024) · Phytomedicine Plus · doi:10.1016/j.phyplu.2024.100704 · Cited by 7
Advantages of introducing an effective crystalline inhibitor in curcumin amorphous solid dispersions formulated by Eudragit E100
Fan, N., Li, J., & Li, J. (2021) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgaa012 · Cited by 7
Drug nanocrystals
Fernandes, A. R., Dias-Ferreira, J., da Silva, C. F., Severino, P. B., Martins‐Gomes, C., Silva, A. M., & Souto, E. B. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813741-3.00011-x · Cited by 7
Formulation and In-Vitro evaluation of Nanocrystal formulation of poorly soluble drugs
Sharma, A., Jain, A. P., & Arora, S. (2020) · Journal of Drug Delivery and Therapeutics · doi:10.22270/jddt.v9i4-s.3873 · Cited by 7
Drug Loading and Dissolution Properties of Dalcetrapib–Montmorillonite Nanocomposite Microparticles
Bodnár, K., Hudson, S. P., & Rasmuson, Å. C. (2020) · Organic Process Research & Development · doi:10.1021/acs.oprd.9b00460 · Cited by 7
Advances in nanocrystals as drug delivery systems
Kaur, A., Parmar, P. K., Jadhav, S., & Bansal, A. K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820757-4.00011-9 · Cited by 7
Efavirenz dissolution enhancement V - A combined top down/bottom up approach on nanocrystals formulation
Sartori, G. J., Prado, L. D., & Rocha, H. V. A. (2022) · Brazilian Journal of Pharmaceutical Sciences · doi:10.1590/s2175-97902022e18800 · Cited by 7
Assessment of Toxicity and Safety Profiles of Nanoparticles
(2020) · Letters in Applied NanoBioScience · doi:10.33263/lianbs101.18771888 · Cited by 8
Drug nanocrystals as drug delivery systems
Misra, S. K., & Pathak, K. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824024-3.00026-9 · Cited by 7
Factors affecting the preparation of nanocrystals: characterization, surface modifications and toxicity aspects
Marques, S. M., & Kumar, L. (2023) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2023.2218084 · Cited by 7
In vitro toxicity assessment of nanocrystals in tissue‐type cells and macrophage cells
Chen, M., Li, Y., Zhou, J., Yang, Z., Wang, Z., Yang, Y., Zhang, H., Li, Z., & Mei, X. (2017) · Journal of Applied Toxicology · doi:10.1002/jat.3570 · Cited by 7
Orally Administered Nanotherapeutics For Parkinson’s Disease: An Old Delivery System Yet More Acceptable
Aggarwal, N., Qamar, Z., Rehman, S., Baboota, S., & Ali, J. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200406072451 · Cited by 7
Polymeric composites of 1,2,4-thiadiazole: solubility, dissolution and permeability assay
Volkova, Т. V., Domanina, E. N., Chislov, M., Proshin, A. N., & Terekhova, I. V. (2019) · Journal of Thermal Analysis and Calorimetry · doi:10.1007/s10973-019-08947-6 · Cited by 7
Regulation of Nanotechnology-Based Products Subject to Health Regulations: Application of Quality by Design (QbD) and Quality Risk Management (QRM)
Dias, A. L., Ferreira, N. N., Ferreira, L. M. B., Pedreiro, L. N., dos Santos, A. M., & Gremião, M. P. D. (2021) · Nanomedicine and nanotoxicology · doi:10.1007/978-3-030-63389-9_13 · Cited by 6
Poorly water-soluble APIs in fixed-dose combinations: development, challenges, and opportunities in manufacturing techniques
Lesutan, V.-N., Andersen, S. K., & Lamprou, D. A. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.107212 · Cited by 6
Introduction to biomaterials for cancer therapeutics
Lee, B. K., Yun, Y., Park, K., & Sturek, M. S. (2013) · Elsevier eBooks · doi:10.1533/9780857096760.1.3 · Cited by 6
Formulation and optimization of novel vesicular elastic carrier for transdermal delivery of lercanidipine for the treatment of hypertension
Peddapalli, H., & Radha, G. V. (2023) · Materials Today Proceedings · doi:10.1016/j.matpr.2023.07.244 · Cited by 6
QbD Based Approach to Enhance the In-Vivo Bioavailability of Ethinyl Estradiol in Sprague-Dawley Rats
Powar, T. A., & Hajare, A. A. (2020) · Acta chimica slovenica · doi:10.17344/acsi.2019.5441 · Cited by 6
Nanoparticle formulation of Syzygium cumini, antioxidants, and diabetes
Bitencourt, P. E. R. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815776-3.00035-8 · Cited by 6
In Vitro Caco-2 Cell Permeability Studies of Ziprasidone Hydrochloride Monohydrate Nanocrystals
Karaküçük, A., Taşhan, E., Öztürk, N., & Çelebi, N. (2020) · Turkish Journal of Pharmaceutical Sciences · doi:10.4274/tjps.galenos.2020.67366 · Cited by 6
Mechanistic study of preparation of drug/polymer/surfactant ternary hot extrudates to obtain small and stable drug nanocrystal suspensions
Omagari, K., Ueda, K., Zhijing, Z., Higashi, K., Inoue, M., Fukami, T., & Moribe, K. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.120003 · Cited by 6
Preparation and characterization of stabilizer-free oily nanosuspensions
Wang, T., & Staufenbiel, S. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.105393 · Cited by 5
3D-printed acyclovir nanocrystals: An advanced approach to herpes simplex treatment
López-Vidal, L., Juskaite, K., Fandiño, O. E., Fuster, M. G., Sangalli, M., Adhami, M., Wang, J., Palma, S. D., Volpe‐Zanutto, F., Larrañeta, E., et al. (2025) · Applied Materials Today · doi:10.1016/j.apmt.2025.102695 · Cited by 5
Advances in Nanomaterials for Targeted Drug Delivery: Emerging Trends and Future Prospects in Nanodrug Development
Ayidh, A. A., Abbas, M. A. E., Parayangat, M., & Ijyas, T. (2025) · Current Cancer Drug Targets · doi:10.2174/0115680096362452250301054711 · Cited by 6
Preclinical studies of N3-O-toluyl-fluorouracil-loaded lipid-based nanosuspensions in H22-bearing mice
Zhang, N., Zhang, J., Li, M., Liu, Z., Wang, L., & Liu, Y. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s59338 · Cited by 5
Evaluation of preclinical formulations for a poorly water-soluble compound
Granath, A.-K., & Sigfridsson, K. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.07.041 · Cited by 5
An Aseptic One-Shot Bottom-Up Method To Produce Progesterone Nanocrystals: Controlled Size and Improved Bioavailability
Zhai, J., Li, Q., Xu, H., Su, T., Wang, Y.-E., Huang, W., Ma, Y., & Guan, S. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b01050 · Cited by 5
Formulation of Ketoconazole Nanocrystal-Based Cryopellets
Touzet, A., Pfefferlé, F., Lamprecht, A., & Pellequer, Y. (2020) · AAPS PharmSciTech · doi:10.1208/s12249-019-1570-1 · Cited by 5
Nanocrystals of a new camptothecin derivative WCN-21 enhance its solubility and efficacy
You, J., Chen, Y., Alsayeh, Z. M., Shen, X., Li, C., Zhao, P., Chen, F., Liu, Y., & Xu, C. (2017) · Oncotarget · doi:10.18632/oncotarget.16159 · Cited by 5
NANOCRYSTALLIZATION OF DAPSONE; A NOVEL APPROACH TO BOOST SOLUBILITY, DISSOLUTION, AND IN-VITRO ANTI-INFLAMMATORY ACTIVITY
Zayed, G., Mohammed, H. M., & Osman, S. K. (2022) · Al-Azhar Journal of Pharmaceutical Sciences/Al-Azhar Journal of Pharmaceutical Sciences · doi:10.21608/ajps.2022.268247 · Cited by 4
Norfloxacin Nanocrystals Through Surfactant Assisted Grinding
Costa, G. D. P., Isquibola, G., Ferreira, P. O., Porto, M. V., Magdalena, A. G., & Caires, F. J. (2024) · Materials Research · doi:10.1590/1980-5373-mr-2024-0195 · Cited by 4
PHARMACEUTICAL NANOCRYSTALS: AN EXTENSIVE OVERVIEW
SIVANATHAN, G., RAJAGOPAL, S., MAHADEVASWAMY, G., ANGAMUTHU, G., & Venkatesh, D. N. (2024) · International Journal of Applied Pharmaceutics · doi:10.22159/ijap.2024v16i6.52257 · Cited by 4
Polymeric Stabilizers for Drug Nanocrystals
Peltonen, L., Tuomela, A., & Hirvonen, J. J. (2015) · doi:10.1002/9781119041559.ch3 · Cited by 4
Pharmacokinetics of nano- and microcrystal formulations of low solubility compounds after intramuscular injection to mice
Aluri, K. C., Sigfridsson, K., Xue, A., & Ramsden, D. (2024) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgae118 · Cited by 3
Celecoxib Reimagined: Multifunctional Roles in Advanced Drug Delivery and Therapeutics
Sharma, K., Kumar, D., Chandna, N., & Kapoor, J. K. (2025) · ChemistrySelect · doi:10.1002/slct.202502652 · Cited by 3
Nanomedicines in Tuberculosis: Diagnosis, Therapy and Nanodrug Delivery
Dakkah, A. N., Bataineh, Y. A., Al-Jaidi, B. A., Bayan, M. F., & Nimer, N. A. (2020) · Engineering materials · doi:10.1007/978-3-030-36260-7_13 · Cited by 3
Comparative Evaluation of Porous Carriers for Dissolution Improvement of BCS Class II Drug
Mahajan, A. N., Yadav, A., Patel, P., Koradia, S. K., Mehta, F., & Shah, K. (2021) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2021.00335 · Cited by 3
Pharmaceutical and Pharmacokinetic Aspects of Nanoformulation Based Drug Delivery Systems for Anti-cancer Drugs
Singh, A. K., Bahadur, S., Yadav, D., & Dabas, H. (2023) · Current Pharmaceutical Design · doi:10.2174/1381612829666230824144727 · Cited by 3
Pure drug nanomedicines - where we are?
Lai, Y., Xie, B., Zhang, W., & He, W. (2025) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(25)60851-x · Cited by 3
Development and Characterization of Nanocarrier Systems for the Delivery of Antitubercular Drugs
Ribeiro, R. (2013) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/b6v3-t472 · Cited by 3
Nanocrystals for Drug Delivery Applications
Tuomela, A. (2015) · Työväentutkimus Vuosikirja · Cited by 3
Crystalline Nanoparticles
Lü, Y., Wu, W., & Li, T. (2018) · doi:10.1002/9781119046233.ch11 · Cited by 3
Ocular Delivery of Natamycin in Fungal Keratitis: Barriers, Advanced Drug Delivery Systems, and Translational Challenges
Prabhu, M., Lale, M. R., Guru, B. R., & Bhandary, S. V. (2026) · Journal of Applied Pharmaceutical Science · doi:10.1177/22313354261443039 · Cited by 2
DEVELOPMENT, OPTIMIZATION AND IN VITRO CHARACTERIZATION OF HALOPERIDOL NANOCRYSTALS USING 32 FACTORIAL DESIGN
Saritha, D., Bose, P. S. C., Osmani, R. A. M., Iriventi, P., Kanna, S., & Ravi, G. (2024) · International Journal of Applied Pharmaceutics · doi:10.22159/ijap.2024v16i3.50412 · Cited by 2
Evaluation of Nano-Niclosamide in Killing Demodex folliculorum In Vitro and the Potential Application in Ocular Surface
Li, J., Ma, P., Guo, S., Qin, D., Wang, Y., Liu, Y., Yang, Z., Huang, C., Han, Y., & Liu, Z. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17030332 · Cited by 2
TRİİYODOANİLİN’İN SENTEZLENMESİ, NANOSÜSPANSİYONLARININ HAZIRLANMASI, İN VİTRO KARAKTERİZASYONU VE RADYOKONTRAST ÖZELLİKLERİNİN İNCELENMESİ
Koca, M., Özakar, E., & Özakar, R. S. (2021) · Ankara Universitesi Eczacilik Fakultesi Dergisi · doi:10.33483/jfpau.811737 · Cited by 2
In vivo behaviors of meloxicam nanocrystals by intravenous administration are not significantly affected by stabilizers
Ma, L., Li, Z., Ye, G., Li, M., Sui, X., Liu, B., Tian, B., Liu, Y., & Fu, Q. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104380 · Cited by 2

Authors: Gao, L., Liu, G., Ma, J., Wang, X., Zhou, L., & Li, X.
Affiliations: First Affiliated Hospital of Chinese PLA General Hospital (CN)
Corresponding author: Gao, Lei
Liu, Guiyang
ORCID: Gao, Lei
Liu, Guiyang
Ma, Jianli
Wang, Xiaoqing
Zhou, Liang
Li, Xiang
Venue: Journal of Controlled Release
Publisher: Elsevier BV
Published: 2012-06
Volume: 160
Issue: 3
Pages: 418-430
ISSN: 0168-3659 (ISSN-L)
DOI: 10.1016/j.jconrel.2012.03.013
OpenAlex: W2041317416
Cited by: 347
References: 159
Citations by year: 2026: 13 · 2025: 20 · 2024: 20 · 2023: 23 · 2022: 31 · 2021: 29 · 2020: 36 · 2019: 26 · 2018: 27 · 2017: 28 · 2016: 36 · 2015: 18 · 2014: 19 · 2013: 19 · 2012: 2
FWCI: 2.30
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
doi.org/10.15223/policy-017 (stm-asf)
doi.org/10.15223/policy-037 (stm-asf)
doi.org/10.15223/policy-012 (stm-asf)
doi.org/10.15223/policy-029 (stm-asf)
doi.org/10.15223/policy-004 (stm-asf)
Locations: Journal of Controlled Release (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advancements in Transdermal Drug Delivery
Keywords: drug nanocrystals, poorly water-soluble drugs, pharmacokinetics, pharmacodynamics, targeted drug delivery, in vivo performance, route of administration, dissolution enhancement
MeSH terms: Animals, Drug Administration Routes, Pharmaceutical Preparations, Humans, Pharmacokinetics, Drug Delivery Systems, Nanoparticles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Drug nanocrystals: in vivo performances.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks